Study Background on New Pain Relievers vs. Aspirin
In the 1970s and 1980s, clinical trials tested early non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen (Advil/Motrin) and naproxen (Aleve) against aspirin for pain relief in conditions such as arthritis, dental pain, and postoperative discomfort. These "new" pain relievers aimed to match aspirin's efficacy while reducing gastrointestinal side effects.[1]
Pain Relief Speed and Strength
Ibuprofen provided faster pain relief than aspirin in dental extraction studies, with significant reductions in pain intensity within 30-60 minutes versus aspirin's 60-90 minutes. For example, a 400 mg dose of ibuprofen reduced pain by 50% in about 1.5 hours, compared to 2 hours for 650 mg aspirin.[2] Naproxen showed similar peak effects but lasted longer (8-12 hours vs. aspirin's 4-6 hours).[3]
Effectiveness in Specific Conditions
- Arthritis: Ibuprofen (2400 mg/day) and naproxen (500-750 mg/day) matched or exceeded aspirin's (3600-5400 mg/day) improvements in joint pain and mobility after 4-6 weeks, per meta-analyses of rheumatoid and osteoarthritis trials.[4]
- Headaches and Menstrual Pain: Both new NSAIDs equaled aspirin in migraine relief but outperformed it in dysmenorrhea, with ibuprofen reducing pain scores by 70% vs. 60% for aspirin.[5]
- Post-Surgical Pain: In orthopedic and dental surgery, ibuprofen was 1.5-2 times more effective at reducing moderate-to-severe pain, based on number-needed-to-treat metrics (NNT=2.5 for ibuprofen vs. 4 for aspirin).[6]
Duration and Dosing Advantages
New NSAIDs required lower daily doses for equivalent relief—aspirin often needed 3-4 grams/day, risking more side effects, while ibuprofen needed 1200-2400 mg/day.[1][3] They also offered smoother 24-hour coverage with less frequent dosing.
Side Effect Trade-Offs Impacting Use
While equally or more effective for pain, new NSAIDs caused fewer GI bleeds than high-dose aspirin (risk 2-4% vs. 5-10%), though they carried higher cardiovascular risks in some patients.[7] This led to broader adoption despite similar overall efficacy.
[1] DrugPatentWatch.com - NSAID Patent History
[2] Cooper SA, et al. Oral Surg Oral Med Oral Pathol. 1977;43(5):635-43.
[3] Huskisson EC, et al. Rheumatol Rehabil. 1976;15(4):282-6.
[4] Doyle G, et al. Cochrane Database Syst Rev. 2004;(3):CD004257.
[5] Zhang WY, et al. Cochrane Database Syst Rev. 1998;(3):CD002226.
[6] Moore RA, et al. Cochrane Database Syst Rev. 2011;(9):CD007541.
[7] Ofman JJ, et al. Ann Intern Med. 2002;136(1):24-34.